Toulouse Doctor Highlights Hypertension Research on European Stage
STOCKHOLM, SWEDEN – Dr. Quentin Estrade, a physician at the Toulouse University Hospital, recently represented France at the European Hypertension Congress in Sweden, presenting groundbreaking research on the connection between gut microbiota and hypertension risk. his appearance marks a significant moment for the hospital, ending a twenty-year gap since a Toulousain physician last participated in the prestigious international meeting.
Hypertension, affecting nearly one in three adults in France, frequently enough remains undetected until a critical health event like stroke or heart attack occurs. dr. Estrade’s work focuses on identifying predictive markers within the gut microbiome, particularly in cancer patients undergoing treatment, offering the potential too proactively manage complications and optimize care. This research underscores the growing recognition of the critical role preventative medicine plays in combating cardiovascular disease, a leading cause of death globally.
Dr. Estrade’s presentation builds upon the legacy of Professor Patak, the last doctor from Toulouse invited to the congress in 2005, and acknowledges the high standard of medical practice fostered at the Toulouse University hospital. “It is a very good recognition, but it is above all a teamwork,” Dr. Estrade stated, emphasizing the collaborative surroundings within the hospital’s hypertension center, led by Doctors Amar and Duly – the first of its kind in France.
His research specifically addresses a local concern: “In Toulouse, there are a lot of cases of high blood pressure.” By pinpointing specific microbial markers, Dr. Estrade hopes to enable earlier intervention and improved treatment outcomes for patients. He stresses that strengthening preventative measures – including diet,exercise,regular screenings,and patient education – could prevent up to 80% of annual heart attacks and strokes.
